DNA-Binding Properties of Bis-N-substituted Tetrandrine Derivatives. 2022

Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
Departamento de Investigación en Polímeros y Materiales, Universidad de Sonora, Rosales y Encinas s/n, Col. Centro, CP 83000 Hermosillo, Sonora, México.

A series of bis-N-substituted tetrandrine derivatives carrying different aromatic substituents attached to both nitrogen atoms of the natural alkaloid were studied with double-stranded model DNAs (dsDNAs) to examine the binding properties and mechanism. Variable-temperature molecular recognition studies using UV-vis and fluorescence techniques revealed the thermodynamic parameters, ΔH, ΔS, and ΔG, showing that the tetrandrine derivatives exhibit high affinity toward dsDNA (K ≈ 105-107 M-1), particularly the bis(methyl)anthraquinone (BAqT) and bis(ethyl)indole compounds (BInT). Viscometry experiments, ethidium displacement assays, and molecular modeling studies enabled elucidation of the possible binding mode, indicating that the compounds exhibit a synergic interaction mode involving intercalation of one of the N-aryl substituents and interaction of the molecular skeleton in the major groove of the dsDNA. Cytotoxicity tests of the derivatives with tumor and nontumor cell lines demonstrated low cytotoxicity of these compounds, with the exception of the bis(methyl)pyrene (BPyrT) derivative, which is significantly more cytotoxic than the remaining derivatives, with IC50 values against the LS-180, A-549, and ARPE-19 cell lines that are similar to natural tetrandrine. Finally, complementary electrochemical characterization studies unveiled good electrochemical stability of the compounds.

UI MeSH Term Description Entries

Related Publications

Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
December 2005, Biochemical and biophysical research communications,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
October 2007, International journal of biological macromolecules,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
October 2016, The Journal of organic chemistry,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
October 2022, Journal of biomolecular structure & dynamics,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
June 2002, Die Pharmazie,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
March 1967, Journal of medicinal chemistry,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
January 1969, Archivum immunologiae et therapiae experimentalis,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
December 1988, Journal of photochemistry and photobiology. B, Biology,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
April 1987, Anti-cancer drug design,
Sandra Mónica González-Martínez, and Drochss Pettry Valencia-Ochoa, and Juan Carlos Gálvez-Ruiz, and Mario Alberto Leyva-Peralta, and Octavio Juárez-Sánchez, and María A Islas-Osuna, and Viviana Isabel Calvillo-Páez, and Herbert Höpfl, and Ramón Íñiguez-Palomares, and Fernando Rocha-Alonzo, and Karen Ochoa Lara
January 1963, Annales medicinae experimentalis et biologiae Fenniae,
Copied contents to your clipboard!